Cervical cytology pattern and human immunodeficiency virus serostatus of women seen in Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
Main Article Content
Abstract
Background: Cervical cancer is the second most common cancer in women worldwide. Human immunodeficiency virus (HIV) has been suggested to be a cofactor in the association between human papillomavirus and cervical intraepithelial neoplasia (CIN).
Aim: To determine the pattern of cervical cytology changes in women of different HIV status and characterise the sociodemographic factors that confound the changes seen.
Methods: This was a cross-sectional comparative study. This study was conducted in Gynaecology Clinic of Ahmadu Bello University Teaching Hospital, Zaria, Nigeria. Following informed consent, 272 HIV-positive (HIV+) and 275 HIV-negative (HIV−) women had questionnaires administered and Papanicolaou smears were taken.
Results: The average age of the respondents was 32.6 ± 6.8 years (range: 15–49 years). Mean parity for HIV+ women was 3.28 and 3.36 for HIV− women while 70.8% of HIV+ women were married comparable with 72.7% in HIV− women. Twenty-nine per cent of HIV+ women had positive smears for CIN compared with 16.4% in those that were HIV−. This was statistically significant (odds ratio = 2.05, P = 0.001). The
high-grade lesions (CIN II and CIN III) tended to be higher in the HIV+ women (11.4%) than the HIV− women (0.7%).
Conclusion: HIV+ women in Zaria, Northern Nigeria, are at higher risk of severe cervical dysplasia compared with their counterparts who are HIV−. It is recommended that greater effort should be made to have an integrated reproductive healthcare service which includes cervical cytology within the HIV clinics.
Downloads
Article Details
The journal grants the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License.
References
1. Thomas J. Olukunle O, Iyare I. Current concepts in cervical carcinogenesis and new perspectives in prevention. Arch Ib Med 2002;3:36‑9.
2. Rowlands PK. Barros‑Lopes A. Invasive carcinoma of the cervix. Curr Obstet Gynaecol 2001;11:172‑7.
3. Waggoner SE. Cervical cancer. Lancet 2003;361:2217‑25.
4. Rostad B, Schei B, da Costa F. Risk factors for cervical cancer in Mozambican women. Int J Gynaecol Obstet 2003;80:63‑5.
5. RobertsAA, Ayankogbe OO, Osisanya TF, BamgbalaAO, AjekigbeAT, Olatunji BS, et al. Knowledge of cervical cancer risk factors among refugee women in Oru camp. Niger Med Pract 2004;46:67‑70.
6. Rafindadi AH, Ifenne I, Shittu SO, Bako AU, Olasinde TA. A study of some aetiological factors in 41 cases of cancer of the cervix uterine in Zaria Niger. Q Hosp Med J 1999;9:87‑9.
7. King CS. Carcinoma of the cervix and cervical cytology – Short epidemiological review Cent. Afr J Med 1992;38:198‑202.
8. Okeke TA, Okafor U, Akpala CO. Epidemiological studies of a cervical cancer screening programme population. Sahel Med J 1999;2:30‑3.
9. U.S. Panel Endorses, Cervical Cancer Vaccine for Girls. Available from: http//www.n/mmhgov/medlineplus/news/fullstory35502htm/.
[Last accessed on 2006 Jun 29].
10. Olaniyan OB, Denny L. Abnomal cytology in HIV‑positive women referred for colposcopy. An analysis of cytology‑colposcopy‑histology
correlation. Trop J Obstet Gynaecol 2005;22:129‑32.
11. Adachi A, Fleming I, Burk RD, Ho GY, Klein RS. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears:
A prospective study of colposcopy and clinical outcome. Obstet Gynecol 1993;81:372‑7.
12. SunXW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr., et al. Human papillomavirus infection in women infected with the
human immunodeficiency virus. N Engl J Med 1997;337:1343‑9.
13. Adewuyi SA, Shittu SO, Rafindadi AH. Cervical cancer in HIV seropositive patients. West Afr J Radiol 2007;14:31‑7.
14. Mandelblatt JS, Kanetsky P, Eggert L, Gold K. Is HIV infection a cofactor for cervical squamous cell neoplasia? Cancer Epidemiol Biomarkers Prev 1999;8:97‑106.
15. World Health Organization. AIDS Epidemic Up Date - World Health Organization UNAIDS/WHO – 2005. Joint United Nations Programme on HIV/AIDS (UNAIDS). Available from: http://www.who.int/hiv/epi-update2005_en.pdf. [Last accessed on 2017 Feb 20].
16. Ellerbrock TV, Chiasson MA, Bush TJ, Xiao‑Wei S, Sawo D, Brudney K, et al. Incidence of cervical squamous intraepithelial lesions in HIV infected women. J Am Med Assoc 2000;283:1031‑7.
17. Johnson JC, Burnett AF, Willet GD, Young MA, Doniger J. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus‑infected women. Obstet Gynecol 1992;79:321‑7.
18. Habib AG, Keshinro IB, Gebi UI, Olatunde BO, Onyemelukwe GC, Kangave D. Clinical presentation of HIV infection in Northern Nigeria and its relationship to CD4 + T‑cell counts. Niger Med Pract 1998;35:3‑8.
19. Langley CL, Benga‑De E, Critchlow CW, Ndoye I, Mbengue‑Ly MD, Kuypers J, et al. HIV‑1, HIV‑2, human papillomavirus infection and cervical neoplasia in high‑risk African women. AIDS 1996;10:413‑7.
20. Saidu R, Abdul IS, Jimoh AA, Olatinwo AW, Obiagha IO, Salame AK. Association of squamous intraepithelial lesions in HIV in Ilorin. Trop J Obstet Gynaecol 2006; 23(Suppl 1):s10.
21. Tanko NM, Echejo GO, Manasseh AN, Mandong BM, Banwat EB, Daru PH. Cervical dysplasia in HIV seropositive women in Nigeria. Highland Med Res J 2006;4:21‑6.
22. Ahdieh L, Muñoz A, Vlahov D, Trimble CL, Timpson LA, Shah K, et al. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus‑seropositive and‑seronegative women. Am J Epidemiol 2000;151:1148‑57.
23. Hluangdansakul W, Phinchantra P, Bowonwatanuwong C. Prevalence of SIL and SCCA in human immunodeficiency virus‑seropositive
women at anonymous clinic in Chonburi hospital. J Med Assoc Thai 2006;89:289‑93.
24. Anorlu RI, Igwilo CI, Akanmu AS, Banjo AA, Odunukwe NN, Okany CC, et al. Prevalence of abnormal cervical smears among patients with HIV in Lagos Nigeria. West Afr J Med 2007;26:143‑7.
25. Chama CM, Nggada H, Gashau W. Cervical dysplasia in HIV infected women in Maiduguri, Nigeria. J Obstet Gynaecol 2005;25:286‑8.
26. Chirenje ZM. HIV and cancer of the cervix. Best Pract Res Clin Obstet Gynaecol 2005;19:269‑76.
27. Motti PG, Dallabetta GA, Daniel RW, Canner JK, Chiphangwi JD, Liomba GN, et al. Cervical abnormalities, human papillomavirus, and human immunodeficiency virus infections in women in Malawi. JInfect Dis 1996;173:714‑7.
28. La Ruche G, You B, Mensah‑Ado I, Bergeron C, Montcho C, Ramon R, et al. Human papillomavirus and human immunodeficiency virus
infections: Relation with cervical dysplasia‑neoplasia in African women. Int J Cancer 1998;76:480‑6.
29. Audu BM, Elnafaty AU, Pindiga HU. Prevalence of abnormal cervical smears from sporadic screening in a gynaecological clinic. Niger Med
Pract 2007;51:114‑8.
30. Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV‑infected women. AIDS 2001;15:2157‑64.
31. Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD. Early regression of cervical lesions in HIV‑seropositive women receiving
highly active antiretroviral therapy. AIDS 1998;12:1459‑64.
32. Massad LS, Evans CT, Minkoff H, Watts DH, Strickler HD, Darragh T, et al. Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus. Obstet Gynecol 2004;104:1077‑85.